Get started
Author

Maria M. Docanto

Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
2010 · Kristy A. Brown, Nicole I. Hunger, et al. · Breast Cancer Research and Treatment · 123
Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer
2020 · Heidi Fettke, Edmond M. Kwan, et al. · European Urology · 63
HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma
2013 · Nirukshi U Samarajeewa, Fangyuan Yang, et al. · Breast Cancer Research · 58
PDF
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype
2023 · Heidi Fettke, Chao Dai, et al. · EBioMedicine · 49
PDF
Prostaglandin E2 Inhibits p53 in Human Breast Adipose Stromal Cells: A Novel Mechanism for the Regulation of Aromatase in Obesity and Breast Cancer
2015 · Xuyi Wang, Maria M. Docanto, et al. · Cancer Research · 48
Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis–targeting Agents in Metastatic Castration-resistant Prostate Cancer
2018 · Sarah Q. To, Edmond M. Kwan, et al. · European Urology · 44
Plasma Cell–Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate Cancer
2021 · Edmond M. Kwan, Chao Dai, et al. · JCO Precision Oncology · 42
PDF
Ghrelin and des-acyl ghrelin inhibit aromatase expression and activity in human adipose stromal cells: suppression of cAMP as a possible mechanism
2014 · Maria M. Docanto, Fangyuan Yang, et al. · Breast Cancer Research and Treatment · 34
PDF
CREB-Regulated Transcription Co-Activator Family Stimulates Promoter II-Driven Aromatase Expression in Preadipocytes
2013 · Nirukshi U. Samarajeewa, Maria M. Docanto, et al. · Hormones and Cancer · 34
PDF
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer
2021 · Hui-Ming Lin, Kevin Huynh, et al. · Prostate Cancer and Prostatic Diseases · 31
IL‐10 suppresses TNF‐α‐induced expression of human aromatase gene in mammary adipose tissue
2018 · Gabriela Martínez‐Chacón, Kristy A. Brown, et al. · The FASEB Journal · 31
Des-acyl ghrelin inhibits the capacity of macrophages to stimulate the expression of aromatase in breast adipose stromal cells
2016 · CheukMan C. Au, Maria M. Docanto, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 29
Obesity-Associated Inflammatory Cytokines and Prostaglandin E2 Stimulate Glucose Transporter mRNA Expression and Glucose Uptake in Primary Human Adipose Stromal Cells
2015 · Maria M. Docanto, Seungmin Ham, et al. · Journal of Interferon & Cytokine Research · 20
VIOLET: A phase I/II trial evaluation of radioligand treatment in men with metastatic castration-resistant prostate cancer with [161Tb]Tb-PSMA-I&T.
2023 · James Patrick Buteau, Louise Kathleen Kostos, et al. · Journal of Clinical Oncology · 17
Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer
2019 · Edmond M. Kwan, Heidi Fettke, et al. · European Urology Focus · 16
Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells
2018 · Chantal Beatrice Magne Nde, Gloria Casas Gimeno, et al. · Journal of Molecular Biology · 15
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
2024 · Lise J Estcourt, Zoe K McQuilten, et al. · The Lancet Haematology · 14
Independent prognostic impact of plasma NCOA2 alterations in metastatic castration‐resistant prostate cancer
2021 · Heidi Fettke, Edmond M. Kwan, et al. · The Prostate · 11
PDF
Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617
2025 · Heidi Fettke, Louise Kostos, et al. · European Urology · 8
Analytical Validation of an Error-Corrected Ultra-Sensitive Ctdna Next-Generation Sequencing Assay
2020 · Heidi Fettke, Jason A Steen, et al. · BioTechniques · 8
Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer
2021 · Edmond M. Kwan, Heidi Fettke, et al. · Translational Andrology and Urology · 4
PDF
Abstract 5614: Genomic aberrations in circulating tumor DNA (ctDNA) and clinical outcomes from [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC)
2023 · Heidi Fettke, Louise Kostos, et al. · Cancer Research · 3
Abstract 2593: AR-V7 and AR-V9 expression is not predictive of response to AR-axis targeting agents in metastatic castration-resistant prostate cancer
2018 · Sarah Q. To, Edmond Kwan, et al. · Cancer Research · 2
Plasma Cell-Free DNA (cfDNA) Concentration and Outcomes in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients Treated with Androgen Receptor Signalling Inhibitors (ARSIs)
2018 · Heidi Fettke, Edmond M. Kwan, et al. · Asia-Pacific Journal of Clinical Oncology · 1
Dysregulated metabolism and the regulation of aromatase in breast adipose stromal cells in obesity and cancer
2012 · Nirukshi U Samarajeewa, Fangyuan Yang, et al. · BMC Proceedings · 1
PDF
Works count: 38
Citation count: 706
H-index: 15
I10-index: 18
Year
Topic
Type